CTI BioPharma
CTIC
#5743
Rank
S$1.51 B
Marketcap
S$11.51
Share price
0.00%
Change (1 day)
23.99%
Change (1 year)

CTI BioPharma (CTIC) - Total assets

Total assets on the balance sheet as of March 2023 : S$0.14 Billion

According to CTI BioPharma 's latest financial reports the company's total assets are S$0.14 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

CTI BioPharma - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2022-12-31S$0.16 B72.39%
2021-12-31S$97.92 M27.09%
2020-12-31S$77.04 M23.49%
2019-12-31S$62.39 M-49.16%
2018-12-31S$0.12 B67.18%
2017-12-31S$73.41 M-20.55%
2016-12-31S$92.39 M-54.74%
2015-12-31S$0.20 B67.42%
2014-12-31S$0.12 B2.69%
2013-12-31S$0.11 B31.73%
2012-12-31S$90.14 M11.84%
2011-12-31S$80.6 M16.76%
2010-12-31S$69.03 M-29.35%
2009-12-31S$97.7 M6.35%
2008-12-31S$91.87 M-13.15%
2007-12-31S$0.10 B-32.25%
2006-12-31S$0.15 B-39.67%
2005-12-31S$0.25 B-14.25%
2004-12-31S$0.30 B21.59%
2003-12-31S$0.24 B-23.41%
2002-12-31S$0.32 B-42.36%
2001-12-31S$0.56 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
S$140.48 B 98,721.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$142.41 B 100,081.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$114.13 B 80,188.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$25.39 B 17,762.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
S$8.81 B 6,097.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$114.00 B 80,096.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$51.59 B 36,194.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel